RODM - ETF AI Analysis
Top Page
Hartford Multifactor Developed Markets (ex-US) ETF (RODM)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Broad International Diversification
Holdings spread across many developed markets like Japan, Canada, Australia, the UK, and Europe help reduce reliance on any single country.
Financial Sector Strength in Top Holdings
Several leading positions are large, well-known financial institutions that have shown strong year-to-date performance, supporting the fund’s returns.
Negative Factors
Heavy Tilt Toward Financials
A large share of the portfolio is in financial companies, which can increase risk if that sector faces a downturn.
Moderate Expense Ratio
The fund’s fees are not especially low for an ETF, which can slightly reduce long-term returns compared with cheaper options.
Limited Technology Exposure
Relatively small weighting in technology stocks means the fund may not fully benefit when tech shares lead the market.
RODM vs. SPDR S&P 500 ETF (SPY)
AUM1.61B
RegionDeveloped Markets
Expense Ratio0.29%
Beta0.48
IssuerHartford
Inception DateFeb 25, 2015
Dividend Yield2.84%
Asset ClassEquity
Index TrackedHartford Risk-Optimized Multi Developed Markets Ex-US Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume76,318
30 Day Avg. Volume73,983
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
44.86Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering216
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RODM Summary
RODM is an ETF that tracks the Hartford Risk-Optimized Multi Developed Markets Ex-US Index, giving you broad exposure to stocks in developed countries outside the U.S., such as Japan, Canada, and the UK. It owns many types of companies, with a lot in financials and industrials, including well-known names like Royal Bank of Canada and ASML Holding. Investors might use this fund to diversify beyond the U.S. and spread their money across many international sectors and sizes. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs, as it uses a multifactor strategy to optimize returns and manage risk.
What would affect this ETF?RODM’s focus on developed markets outside the U.S. could benefit from economic recovery or growth in regions like Europe and Asia, particularly in sectors such as financials and healthcare, which have significant weight in the ETF. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in these regions could negatively impact the performance of its top holdings, including companies like Nokia and Roche Holding AG. Additionally, currency fluctuations between the U.S. dollar and foreign currencies may influence returns for U.S.-based investors.
RODM Top 10 Holdings
RODM leans heavily on international health care and financial names, with pharma giants like Roche, Novartis, GSK, and Astellas quietly steering the ship. Astellas has been rising and giving the fund a helpful lift, while Roche and Novartis are more steady, adding ballast rather than fireworks. On the financial side, Bank of Montreal has been a solid contributor, and Millicom’s strong run has added some extra juice. Ericsson, however, has been lagging, acting like a small anchor on an otherwise broadly diversified, non-U.S. developed markets portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 1.04% | $16.82M | ― | ― | ― | |
| TotalEnergies SE | 0.99% | $16.10M | €168.98B | 45.67% | 78 Outperform | |
| GlaxoSmithKline | 0.93% | $15.10M | $96.85B | 5.84% | 77 Outperform | |
| Telefonaktiebolaget LM Ericsson Class B | 0.93% | $15.05M | kr307.07B | 16.82% | 72 Outperform | |
| ― | 0.92% | $14.81M | ― | ― | ― | |
| Roche Holding AG | 0.89% | $14.46M | $335.53B | 17.48% | 73 Outperform | |
| Novartis AG | 0.89% | $14.44M | CHF219.59B | 15.32% | 80 Outperform | |
| Astellas Pharma | 0.89% | $14.33M | $26.45B | 32.98% | 69 Neutral | |
| Bank Of Montreal | 0.88% | $14.21M | C$165.34B | 28.20% | 74 Outperform | |
| Millicom International Cellular SA | 0.88% | $14.18M | $14.60B | 82.88% | 71 Outperform |
RODM Technical Analysis
Negative
―
Price Trends
41.82
Negative
41.21
Negative
39.94
Positive
Market Momentum
-0.30
Positive
38.73
Neutral
15.97
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RODM, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 41.61, equal to the 50-day MA of 41.82, and equal to the 200-day MA of 39.94, indicating a neutral trend. The MACD of -0.30 indicates Positive momentum. The RSI at 38.73 is Neutral, neither overbought nor oversold. The STOCH value of 15.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RODM.
RODM Peer Comparison
Comparison Results
Performance Comparison
RODM
Hartford Multifactor Developed Markets (ex-US) ETF
40.80
6.12
17.65%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents